Dicerna Pharmaceuticals, Inc.

ACTIVE

75 Hayden Ave, 马萨诸塞州米德尔塞克斯县, Massachusetts, United Stateswww.dicerna.comPublic302 employeesEstablished: 2007-01-01

Part of Novo Nordisk A/S

Clinical Trials

21 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2007

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

83.3%

Phase 2

8.3%

Trial Status Distribution

Active, not recruiting

83.3%

Completed

12.5%

Not yet recruiting

4.2%

Clinical Trials

Trials sponsored by this organization (24)

Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria

Phase 2

Completed

interventional

May 202236 participants

edosiran in Pediatric Patients from Birth to 11 Years of Age with PH1, PH2, or PH3 and Relatively Intact Renal Functio

Phase 1

Active, not recruiting

Jul 202125 participants

edosiran in Pediatric Patients from Birth to 5 Years of Age with PH1, PH2, or PH3 and Relatively Intact Renal Functio

Phase 1

Active, not recruiting

Jun 202115 participants

edosiran in Pediatric Patients from Birth to 11 Years of Age with PH1, PH2, or PH3 and Relatively Intact Renal Functio

Phase 1

Active, not recruiting

Jun 202125 participants

Study for patients with Primary Hyperoxaluria and Severe Renal Impairment to evaluate the efficacy, safety and tolerability of DCR-PHXC

Phase 1

Active, not recruiting

Sep 202024 participants

Study for patients with Primary Hyperoxaluria to evaluate the efficacy, safety and tolerability of DCR-PHXC

Phase 1

Active, not recruiting

Apr 201936 participants

Study for patients with Primary Hyperoxaluria to evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injectio

Phase 1

Active, not recruiting

Apr 201950 participants

Study for patients with Primary Hyperoxaluria to evaluate the Long-Term Safety and Efficacy of DCR-PHXC Solution for Injectio

Phase 1

Active, not recruiting

Apr 201950 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations